A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Inclusion Criteria: * adult patients, \>=18 years of age; * documented inoperable, locally advanced, metastatic or recurrent non-squamous NSCLC; * adequate liver and kidney function; * women of childbearing potential must have a negative serum pregnancy test within 7 days of starting study treatment. Exclusion Criteria: * prior chemotherapy or treatment with another systemic cancer therapy; * surgery (including open biopsy), significant traumatic injury, or radiotherapy within the last 4 weeks prior to first dose of study treatment; * brain metastasis or spinal cord compression; * fertile men, and women of childbearing potential, not using adequate contraception; * treatment with any other investigational agent, or participation in another clinical trial, within 30 days prior to entering the study.